Alfred K. Cheung

Alfred K. Cheung is a Professor of Internal Medicine and faculty member in the Division of Nephrology & Hypertension at the University of Utah School of Medicine. He currently serves as the Vice Chair for Research in the Department of Internal Medicine and is Board certified in both Internal Medicine and Nephrology by the American Board of Internal Medicine.

• Fellowship Research Nephrology - University of California - San Diego
• Fellowship Clinical Nephrology - University of California - San Diego
• Residency Internal Medicine - Loma Linda University
• Internship - Loma Linda University
• Medical Degree - Albany Medical College
• Undergraduate - State University of New York

Dr. Cheung's primary research interests focus on clinical aspects of chronic kidney disease, hemodialysis, and hypertension. His work spans multiple areas including vascular access complications, mineral metabolism disorders in kidney disease, diabetic nephropathy, and blood pressure management in dialysis patients. His research has significantly contributed to understanding the pathophysiology of vascular access stenosis, the role of vitamin D and fibroblast growth factor 23 in hemodialysis outcomes, and the impact of blood pressure control strategies on renal and cardiovascular outcomes.

Analysis of Dr. Cheung's recent publications reveals a consistent focus on critical issues in nephrology practice, particularly the management of hypertension in kidney disease, vascular access complications, and mineral bone disorders. His work often involves large clinical trials such as the SPRINT study and HEMO study, demonstrating his leadership in major multicenter research efforts. His publications span basic science investigations using animal models to large epidemiological studies examining racial disparities and geographic variations in kidney disease care.

While specific awards are not mentioned in the provided text, Dr. Cheung's extensive publication record in high-impact journals and leadership roles in major clinical trials suggest significant recognition within the nephrology community.

Dr. Cheung has been actively involved in numerous research grants, particularly as a key investigator in the Hemodialysis (HEMO) Study and the Systolic Blood Pressure Intervention Trial (SPRINT). His work has examined various aspects of dialysis adequacy, vascular access complications, and blood pressure management in kidney disease. He has also contributed to research on mineral metabolism, diabetic nephropathy, and racial disparities in kidney disease outcomes. His laboratory work has focused on understanding the mechanisms of vascular access stenosis using porcine models and developing novel therapeutic approaches to prevent these complications.

Dr. Cheung's research has been conducted both within the University of Utah's Department of Internal Medicine and through extensive collaborations with other institutions. His work on vascular access complications has involved specialized laboratories studying arteriovenous graft stenosis, while his clinical research has leveraged large datasets from national studies like HEMO and SPRINT. His research program bridges basic science investigations with clinical epidemiology and outcomes research, creating a comprehensive approach to understanding and addressing challenges in kidney disease care.